Enharncement of the hemolytic activity of the second component of human complement by oxidation
about
Complement receptor is an inhibitor of the complement cascadeThe reaction of iodine and thiol-blocking reagents with human complement components C2 and factor B. Purification and N-terminal amino acid sequence of a peptide from C2a containing a free thiol groupThe purification and properties of the second component of guinea-pig complementInteraction of beta1H globulin with cell-bound C3b: quantitative analysis of binding and influence of alternative pathway components on bindingHuman complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solutionModulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivatorInhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranesRelease of trapped marker from liposomes by the action of purified complement components.Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patientsChemotactic activity derived from interaction of factors D and B of the properdin pathway with cobra venom factor or C3BCombined studies of complement receptor and surface immunoglobulin-bearing cells and sheep erythrocyte rosette-forming cells in normal and leukemic human lymphocytesStructural heterogeneity of C2 Complement protein and its genetic variants in man: a new polymorphism of the HLA region.Third component of complement (C3): structural properties in relation to functionsHereditary deficiency of the fifth component of complement in man. I. Clinical, immunochemical, and family studiesLysis of complement-sensitive Entamoeba histolytica by activated terminal complement components. Initiation of complement activation by an extracellular neutral cysteine proteinaseMechanism of resistance to complement-mediated killing of bacteria encoded by the Salmonella typhimurium virulence plasmid gene rck.The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.The enhancement of bacterial phagocytosis by serum. The role of complement components and two cofactors.Receptor for soluble C3 and C3b on human lymphoblastoid (RAJI) cells. Properties and biologocal significance.Activation of the guinea pig alternative complement pathway by mouse IgA immune complexes.Characterization of the lymphocyte membrane receptor for factor H (beta 1H-globulin) with an antibody to anti-factor H idiotype.Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes.Control of the function of substrate-bound C4b-C3b by the complement receptor Cr1.Human platelet activation by C3a and C3a des-arg.Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody.Human megakaryocytes. V. Changes in the phenotypic profile of differentiating megakaryocytes.Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes. Studies on C9 binding and incorporation into high molecular weight complexes.Isolation and analysis of the mechanism of action of an inactivator of C4b in normal human serumStudies on human plasma C1 inactivator-enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsin.Immunological properties of glycolipids from membranes of Acholeplasma laidlawii.Cytolytic lymphocytic cells with complement receptor in human blood. Induction of cytolysis by IgG antibody but not by target cell-bound C3.Molecular analysis of the membrane attack mechanism of complement.Specificity of human lymphocyte complement receptors.The eighth component of human complement (C8): isolation, characterization, and hemolytic efficiencyFormation and biologic role of polyoma virus-antibody complexes. A critical role for complement.The effects of iodine and thiol-blocking reagents on complement component C2 and on the assembly of the classical-pathway C3 convertase.The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and BbThe Gly-54-->Asp allelic form of human mannose-binding protein (MBP) fails to bind MBP-associated serine proteaseEffect of sodium chloride concentration on fluid-phase assembly and stability of the C3 convertase of the classical pathway of the complement system.The low C5 convertase activity of the C4A6 allotype of human complement component C4.
P2860
Q24302183-E9AF4CB1-E64C-4E73-862F-CF6CF29CDFE7Q24529834-E1BB1AD0-3B67-4445-9891-BCA952962B3BQ24530130-AEF27621-0E62-4759-87D5-DCAC8F7403AEQ24684253-7C4020FF-0948-44E6-A4B3-B0526FBA1932Q24684822-95FD281A-BB19-44B2-896B-39EA54B460E3Q28610968-238225BF-83BF-4FF8-8704-6A13D35008F8Q28610983-9CF8C122-9D28-4CFF-A0D8-F66E2594059BQ33818414-911F4C87-6BF8-40EB-8F5D-35A798DE178BQ33902027-7061DE9D-97FB-4A41-9363-4CB7AD3E2FE6Q34475397-DEC5CCE8-0B6E-48ED-9B7F-5C77C4AAFD4BQ34499033-09EDD418-958E-4967-A5C7-4EFB3AD812C0Q35019966-8615EEED-81AA-4233-B226-71B8B368A01DQ35080082-5F9FBF6C-54FD-412A-9F92-042CF4482312Q35202075-FD7FFB00-6D3D-4F0D-8DAF-FBFE22E1B92CQ35816948-F91F5310-B296-4464-882C-F33DEC3426C9Q35822024-7EB7DBDA-4775-4424-9C9B-E2EB0E0B79F7Q36268987-B06284A1-4F5C-41EC-AABA-4D5D021D1C71Q36269730-7CF68E2B-07FD-457B-9909-5B90E6DCE4B9Q36272983-6DD292D6-6DE8-4FB1-AFED-AE5E735FC7FEQ36346053-8BC805CD-BC89-4652-B7B7-6DD536E1170FQ36346502-A6AF3AFC-0548-42B1-B100-C5F2F5ACF268Q36347257-F8F4D5F1-A6C6-4440-8279-CE91EA201906Q36348868-0C6B59FE-AF55-46A8-8582-48656B1E0700Q36348940-5BB9FA20-BAB6-45EE-82B4-C4B97A09A7F0Q36349022-A1D4DA08-150A-402A-925D-5CA6F888A4ECQ36349924-DB203029-4F67-4EC7-B4A0-0F8C9E24CDFCQ36352993-2E97065C-1E7D-4916-B4F9-E58D636F1201Q39323582-BE92954E-75F8-4714-AE6F-30DFE841CC01Q39729130-B86CFB81-7A67-4203-B533-213A979A0D9CQ40881578-219B996C-6E71-4FC8-BA3C-59E24E5FBF54Q41762557-011A57DB-4ACF-4132-8465-63B89567FE3BQ41785721-3FF9C34E-6F1A-425F-8C29-CD94AF1DBDB5Q41832075-527C17A6-EC93-46DD-9F08-A5978D3C2751Q42000787-A8CB5F9D-7CD6-4C1F-A57C-B329E711A182Q42019298-8D86F194-9B8A-443D-B3FC-1A25FC913A09Q42091709-47463D28-3CAC-4372-A839-2D19CC8F0734Q42120233-D0644723-5532-4AFD-9CC7-A0BD0134C7BDQ42160405-A103751C-1E87-4BE6-9007-00B2D4BC811EQ42162099-C77D304A-3737-4673-99FB-551399CECA96Q42163169-2651B466-C570-486F-A796-C27AFE8DC17A
P2860
Enharncement of the hemolytic activity of the second component of human complement by oxidation
description
1967 nî lūn-bûn
@nan
1967年の論文
@ja
1967年論文
@yue
1967年論文
@zh-hant
1967年論文
@zh-hk
1967年論文
@zh-mo
1967年論文
@zh-tw
1967年论文
@wuu
1967年论文
@zh
1967年论文
@zh-cn
name
Enharncement of the hemolytic ...... human complement by oxidation
@en
type
label
Enharncement of the hemolytic ...... human complement by oxidation
@en
prefLabel
Enharncement of the hemolytic ...... human complement by oxidation
@en
P2860
P356
P1476
Enharncement of the hemolytic ...... human complement by oxidation
@en
P2093
Müller-Eberhard HJ
P2860
P304
P356
10.1084/JEM.126.6.1013
P407
P577
1967-12-01T00:00:00Z